Biotech News
-
FendX to Present at the Hidden Gems Conference and Available for Investor Meetings
October 18, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
Zentek Completes Return on Investment Analysis for Canadian Healthcare System
October 17, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company…
-
Zentek Announces Voting Results of Annual and Special Meeting
October 10, 2023 (Source) — Zentek Ltd. (Nasdaq: ZTEK) (TSXV: ZEN) (“Zentek” or the “Company”), an intellectual property development…
-
Zentek Announces Successful Aptamer Testing for Longevity of Protection and Minimum Effective Dose
October 10, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction
Results Demonstrate the Active Pharmaceutical Ingredient in Cardiol’s Novel CRD-38 Formulation Attenuates Harmful Fat Distribution and Key Markers…
-
DIAGNOS AI Retina Analysis is being deployed across Canada’s Largest Specialist Care Provider in Diabetes & Endocrinology
October 5, 2023 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian…
-
Zentek Announces the Launch of Subsidiary for Aptamer-Based Platform Technology
October 5, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization…
-
Zentek Provides Corporate Update
October 4, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company…
-
Hemostemix Closed $320,125 Private Placement
October 3, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
FendX Successfully Completes Pilot Run to Manufacture REPELWRAP(TM) Film using Dunmore’s Commercial Equipment
October 3, 2023 (Source) — Over 5,000 feet of REPELWRAP™ film was produced using Dunmore’s commercial manufacturing line.…
